» Articles » PMID: 23220258

Regulation of Wound Healing and Organ Fibrosis by Toll-like Receptors

Overview
Specialties Biochemistry
Biophysics
Date 2012 Dec 11
PMID 23220258
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic injury often triggers maladaptive wound healing responses leading to the development of tissue fibrosis and subsequent organ malfunction. Inflammation is a key component of the wound healing process and promotes the development of organ fibrosis. Here, we review the contribution of Toll-like receptors (TLRs) to wound healing with a particular focus on their role in liver, lung, kidney, skin and myocardial fibrosis. We discuss the role of TLRs on distinct cell populations that participate in the repair process following tissue injury, and the contribution of exogenous and endogenous TLR ligands to the wound healing response. Systemic review of the literature shows that TLRs promote tissue repair and fibrosis in many settings, albeit with profound differences between organs. In particular, TLRs exert a pronounced effect on fibrosis in organs with higher exposure to bacterial TLR ligands, such as the liver. Targeting TLR signaling at the ligand or receptor level may represent a novel strategy for the prevention of maladaptive wound healing and fibrosis in chronically injured organs. This article is part of a Special Issue entitled: Fibrosis: Translation of basic research to human disease.

Citing Articles

5-Methoxytryptophan Protects against Toll-Like Receptor 2-Mediated Renal Tissue Inflammation and Fibrosis in a Murine Unilateral Ureteral Obstruction Model.

Wu J, Lee G, Chueh Y, Kuo C, Hsu Y, Wu K J Innate Immun. 2025; 17(1):78-94.

PMID: 39773569 PMC: 11801855. DOI: 10.1159/000543275.


Comparative analysis of human and mouse transcriptomes during skin wound healing.

Wang M, Zhang J, Qiao C, Yan S, Wu G Front Cell Dev Biol. 2024; 12:1486493.

PMID: 39534398 PMC: 11554618. DOI: 10.3389/fcell.2024.1486493.


Fibrosis and Hepatocarcinogenesis: Role of Gene-Environment Interactions in Liver Disease Progression.

Banerjee A, Farci P Int J Mol Sci. 2024; 25(16).

PMID: 39201329 PMC: 11354981. DOI: 10.3390/ijms25168641.


Toll-like receptor 5 tunes hepatic and pancreatic stellate cells activation.

Di Fazio P, Mielke S, Bohm I, Buchholz M, Matrood S, Schuppan D BMJ Open Gastroenterol. 2023; 10(1).

PMID: 37433685 PMC: 10347502. DOI: 10.1136/bmjgast-2023-001148.


Endothelial Dysfunction in Patients Undergoing Cardiac Surgery: A Narrative Review and Clinical Implications.

Knezevic D, Curko-Cofek B, Batinac T, Laskarin G, Rakic M, Sostaric M J Cardiovasc Dev Dis. 2023; 10(5).

PMID: 37233179 PMC: 10218891. DOI: 10.3390/jcdd10050213.


References
1.
Leemans J, Butter L, Pulskens W, Teske G, Claessen N, van der Poll T . The role of Toll-like receptor 2 in inflammation and fibrosis during progressive renal injury. PLoS One. 2009; 4(5):e5704. PMC: 2682651. DOI: 10.1371/journal.pone.0005704. View

2.
Kinnebrew M, Pamer E . Innate immune signaling in defense against intestinal microbes. Immunol Rev. 2011; 245(1):113-31. PMC: 4624287. DOI: 10.1111/j.1600-065X.2011.01081.x. View

3.
Szabo G, Velayudham A, Romics Jr L, Mandrekar P . Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll-like receptors 2 and 4. Alcohol Clin Exp Res. 2005; 29(11 Suppl):140S-145S. DOI: 10.1097/01.alc.0000189287.83544.33. View

4.
Beck J, Young V, Huffnagle G . The microbiome of the lung. Transl Res. 2012; 160(4):258-66. PMC: 3440512. DOI: 10.1016/j.trsl.2012.02.005. View

5.
Zaldivar M, Pauels K, von Hundelshausen P, Berres M, Schmitz P, Bornemann J . CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosis. Hepatology. 2010; 51(4):1345-53. DOI: 10.1002/hep.23435. View